DOLOMITE NEAT ID Network Study: A prospective, multi-site observational study to define the safety and effectiveness of Dolutegravir use in HIV positive pregnant women (208759) First published 30/05/2018 Last updated 17/09/2025 EU PAS number:EUPAS24237 Study Ongoing